Intra-gastric balloon, an aid for Wight reduction in obese patient
Professor Nashwan Qahtan Mahgoob
Department of surgery
College of medicine
University of Mosul
Back ground/aim: Obesity is a medical condition in which excess body fat has accumulated to an extent that it may cause adverse effect on health and regarded is one of a leading preventable cause of death worldwide. Many conservative ways have been used to decrease body weight including diet regime, physical exercise, drugs and balloon insertion into the stomach. More advanced way including surgical intervention to decrease stomach size or bypass small bowel. In this study, we share our experience with MedSil intra-gastric balloon to evaluate the safety, tolerability and efficacy for patients with class one and two obesity. Methods: From January 2015 to January 2017, MedSil intra-gastric balloons were inserted in stomachs of 85 patients at the endoscopy unit in CMC Hospital Erbil/Kurdistan/ Iraq. All the patients had a body mass index between 30 to 39 kg/m2 and were within the age range of 17-50 with a mean age of 29 years, there were 55 female 30 male patients. After using special criteria for their selection, the patients underwent consent, pre balloon insertion investigation tests and anesthesia evaluation. The balloon was inserted via upper endoscopy device after diagnostic study and then it was filled with 550-600 mls of stained saline. All patients’ were given an analgesic and antiemetic for a week and anti-secretory proton pump inhibitors for 6 months. Diet and the importance of the exercise were part of the program phase and protocol. The balloon was removed after 6 months. The patients were followed during the 6 months of insertion and 6 months after the removal. The weight reduction and complications were documented and reported.
Results: Satisfactory weight loss obtained in 85% of patients after six months and 75% after 12 from insertion respectively. One patient underwent early removal of balloon after 7 days of insertion; other patient had balloon leak and shrinkage which necessitated replacement by another one. Early post-operative pain and vomiting were universal but subsided in 90% during the first 10 days. Conclusion: Intra gastric balloon for the treatment of obesity seem to reduce body weight under certain selection.
key word: Obesity. Intra-gastric balloon. Weight reduction. MedSil balloon
Obesity has reached a level of a big health problem in the world. The World Health Organization reports that worldwide, more than one billion people are overweight and at least 500 million of whom are severely obese. An estimated 115 million of these people will develop serious medical conditions, including diabetes mellitus, cardiovascular diseases, stroke, liver problems, and cancer. Studies show that those potentially life threatening conditions can be improved with weight loss. 1,2 . Effective weight management for individuals with obesity can be carried on by many ways, what with a trail of pharmacological approaches was not achieving any significant outcomes 3. Bariatric surgery has provided significant weight reduction and gained popularity, but there is a price to pay, for there could be complications in the procedure and its outcome, as well as associated major morbidities and even mortality. There is, therefore, a growing demand for less invasive approaches.
Since 1982, intra-gastric balloons have been used to induce early satiety by decreasing the capacity of the gastric reservoir, thereby reducing food intake leading to weight loss. Gastric balloons have been upgraded and improved and a number of papers on them with conflicting results have been published4,5,6 .
This paper, presents our experience of the safety, tolerance and weight reduction efficacy of the MedSil intra-gastric balloon in class one and two obese patients in our region. Read More